The classification screen

4 questions before you choose the route.

This page identifies the right question and evidence. It does not determine the legal outcome on a reader’s facts.

01

Special or general cosmetic?

Class.

Class
02

Notification/registration done?

NMPA path.

Path
03

Chinese label compliant?

Label.

Label
04

Claims that are ads/medical?

Resolve the claims that are ads/medical question separately before choosing the route.

Ads

Working rule: China cosmetics regulation centres on NMPA pathways: notification or registration depending on product class, plus Chinese labelling and safety assessment expectations.

What changes the answer

The signal ledger.

These facts move the question beyond a label and into a product, money-flow and control analysis.

Signal
Ask the operating question
Why it changes the route
Drug claims on cream
Crosses into drug/device risk.
Stop.
CBEC forever strategy for every SKU
Unreliable.
Map.
Ignore responsible person role
Accountability gap.
Appoint.
Prepare before you escalate

Bring a compact evidence docket—not a pitch deck.

Give a compliance team or counsel the operating facts that reveal the perimeter.

01NMPA filing/registration numbersStatus.
02Safety assessment packSupport.
03Label artworkChinese particulars.
Common confusions

Questions people ask before they build.

Short answers for orientation. The right result can change with the service model and current rules.

Is toothpaste a cosmetic?

Category lines exist — classify carefully under current rules.

Where is influencer risk?

Use the linked specialist resource when Cosmetics Compliance in China turns on detailed evidence, procedure or risk assessment.

Primary authorities

Reviewed sources support orientation, not a fact-specific assessment.